A detailed history of Johnson & Johnson transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Johnson & Johnson holds 1,074,658 shares of VOR stock, worth $859,726. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,074,658
Previous 1,074,658 -0.0%
Holding current value
$859,726
Previous $2.55 Million 57.82%
% of portfolio
0.37%
Previous 0.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$12.24 - $20.38 $13.2 Million - $21.9 Million
1,074,658 New
1,074,658 $16.9 Million

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $30.4M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.